Clinical outcomes of twice-weekly teriparatide acetate administration in osteoporosis
The continuation rate of W2TPD was 47% and resulted in particularly favorable BMD gains in the spine. It was also discovered to be effective in increasing BMD even when following bisphosphonate treatment.
Authors
- Yasushi Terayama
- Hideharu Nishi
- Keiji Wada (ORCID: https://orcid.org/0000-0002-5441-1126)
- Ayako Tominaga (ORCID: https://orcid.org/0000-0002-2280-9287)
- Hideyuki Maruki
- Yoshiharu Kato (ORCID: https://orcid.org/0009-0000-3076-6267)
- Ken Okazaki (ORCID: https://orcid.org/0000-0003-1274-8406)
Institutions
- Tokyo Women's Medical University (JP)
- Dainichiseika (Japan) (JP)
- Tsurugi Hospital (JP)
- Shiseikai Daini Hospital
- Saitama Medical University (JP)
Publication Details
- Journal
- Archives of Osteoporosis
- Published
- 2025-11-19
- DOI
- https://doi.org/10.1007/s11657-025-01622-4
- Primary Topic
- Bone health and osteoporosis research
- Type
- article
- Field-Weighted Citation Impact
- 0.00